logo

For the Inventor, By the Inventor

Osaka, Japan

Kouji Hattori

This inventor holds 15 USPTO granted patents. Top assignees: Fujisawa Pharmaceutical Company, Ltd., Astellas Pharma Gmbh. Active years: 1998-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kouji Hattori. Retrieved from https://idiyas.com/inventor/kouji-hattori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 66.7

Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 152(Granted Patents)


Location History:

  • Takarazuka, JP (1998 - 2002)
  • Osaka, JP (2003 - 2009)
  • Chuo-ku, JP (2011)

Company Filing History:

goldMedal12 out of 940 
 
Fujisawa Pharmaceutical Company, Ltd.
 patents
silverMedal3 out of 424 
 
Astellas Pharma Gmbh
 patents

Years Active: 1998-2011

Loading Chart...
15 patents (USPTO):Explore Patents
1. 7928264 - Aminoalcohol derivatives (2011-04-19),
2. 7629366 - Aminoalcohol derivatives (2009-12-08),
3. 7417060 - Aminoalcohol derivatives (2008-08-26),
4. 7037938 - Aminoalcohol derivatives (2006-05-02),
5. 6660759 - 4.5-diaryloxazole compounds with prostaglandin I2 (PGI2) agonistic activity (2003-12-09),
6. 6437146 - Oxazole compounds as prostaglandin e2 agonists or antagonists (2002-08-20),
7. 6384072 - Benzocycloheptene derivatives (2002-05-07),
8. 6303649 - Naphthalene derivatives (2001-10-16),
9. 6300344 - Heterocyclic compounds (2001-10-09),
10. 6297267 - 4,5-diaryloxazole compounds (2001-10-02),
11. 6245790 - Oxazole compounds useful as PGE2 agonists and antagonists (2001-06-12),
12. 6025375 - 4,5-diaryloxazole derivatives (2000-02-15),
13. 5972965 - 4,5-diaryl oxazole derivatives (1999-10-26),
14. 5863918 - Naphthalene derivatives (1999-01-26),
15. 5763489 - Naphthalene derivatives as prostaglandin I.sub.2 agonsists (1998-06-09),

Title: Kouji Hattori: Innovator in Aminoalcohol Derivatives

Introduction

Kouji Hattori is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of aminoalcohol derivatives. With a total of 15 patents to his name, Hattori's work has had a substantial impact on therapeutic treatments.

Latest Patents

One of Hattori's latest patents involves aminoalcohol derivatives, which relate to a compound of the formula [I]. This invention addresses various compounds where specific groups are defined, including hydrogen, halogen, lower alkyl, and hydroxy. The compound is useful for the prophylactic and therapeutic treatment of conditions such as ulcers and overactive bladder. The detailed structure and potential applications of these compounds highlight Hattori's innovative approach to pharmaceutical development.

Career Highlights

Throughout his career, Kouji Hattori has worked with notable companies in the pharmaceutical industry. He has been associated with Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in drug development.

Collaborations

Hattori has collaborated with esteemed colleagues, including Akira Tanaka and Kiyoshi Taniguchi. These partnerships have fostered a collaborative environment that has led to innovative solutions in the pharmaceutical sector.

Conclusion

Kouji Hattori's contributions to the field of aminoalcohol derivatives exemplify his dedication to innovation in pharmaceuticals. His extensive patent portfolio and collaborative efforts underscore his role as a key figure in advancing therapeutic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…